Enhanced anti-angiogenic effect of E7820 in combination with erlotinib in epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer xenograft models.
about
Aggretin Venom Polypeptide as a Novel Anti-angiogenesis Agent by Targeting Integrin alpha2beta1.Noninvasive Bioluminescence Imaging of AKT Kinase Activity in Subcutaneous and Orthotopic NSCLC Xenografts: Correlation of AKT Activity with Tumor Growth Kinetics.Antisense therapeutics in oncology: current status.Bronchial Artery Angiogenesis Drives Lung Tumor Growth.Antitumor effects of eribulin depend on modulation of the tumor microenvironment by vascular remodeling in mouse models.Synergistic tumor suppression by a Perilla frutescens-derived methoxyflavanone and anti-cancer tyrosine kinase inhibitors in A549 human lung adenocarcinoma.
P2860
Enhanced anti-angiogenic effect of E7820 in combination with erlotinib in epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer xenograft models.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Enhanced anti-angiogenic effec ...... lung cancer xenograft models.
@ast
Enhanced anti-angiogenic effec ...... lung cancer xenograft models.
@en
type
label
Enhanced anti-angiogenic effec ...... lung cancer xenograft models.
@ast
Enhanced anti-angiogenic effec ...... lung cancer xenograft models.
@en
prefLabel
Enhanced anti-angiogenic effec ...... lung cancer xenograft models.
@ast
Enhanced anti-angiogenic effec ...... lung cancer xenograft models.
@en
P2093
P2860
P356
P1433
P1476
Enhanced anti-angiogenic effec ...... lung cancer xenograft models.
@en
P2093
Makoto Asada
Taro Semba
Toshiaki Wakabayashi
Toshimitsu Uenaka
Yasuhiro Funahashi
P2860
P304
P356
10.1111/CAS.12450
P577
2014-08-01T00:00:00Z